Encompass Health (EHC) Price Target Raised to $64.00 at Royal Bank of Canada
Encompass Health (AMEX:EHC) had its price target lifted by Royal Bank of Canada to $64.00 in a research report sent to investors on Thursday, The Fly reports. They currently have an outperform rating on the stock.
Other research analysts have also recently issued research reports about the company. Zacks Investment Research raised Encompass Health from a hold rating to a buy rating and set a $60.00 target price on the stock in a research report on Tuesday, January 30th. Credit Suisse Group began coverage on Encompass Health in a research report on Wednesday, January 17th. They set an outperform rating and a $58.00 target price on the stock. Stephens reaffirmed a buy rating and set a $55.00 target price on shares of Encompass Health in a research report on Friday, January 12th. Wells Fargo & Co began coverage on Encompass Health in a research report on Tuesday, January 30th. They set a market perform rating and a $56.00 target price on the stock. Finally, William Blair reaffirmed an outperform rating on shares of Encompass Health in a research report on Tuesday, November 21st. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and eight have assigned a buy rating to the stock. Encompass Health presently has a consensus rating of Hold and an average target price of $58.00.
Encompass Health (EHC) opened at $55.08 on Thursday. The stock has a market capitalization of $5,410.00, a P/E ratio of 20.32, a P/E/G ratio of 1.70 and a beta of 0.48. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 1.89. Encompass Health has a 1 year low of $40.86 and a 1 year high of $56.13.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, April 16th. Shareholders of record on Monday, April 2nd will be given a $0.25 dividend. The ex-dividend date is Thursday, March 29th. This represents a $1.00 annualized dividend and a yield of 1.82%. Encompass Health’s dividend payout ratio is currently 36.90%.
A number of hedge funds have recently bought and sold shares of EHC. FNY Managed Accounts LLC purchased a new position in Encompass Health in the fourth quarter worth $125,000. Cerebellum GP LLC purchased a new position in Encompass Health in the fourth quarter worth $129,000. Heartland Advisors Inc. purchased a new position in Encompass Health in the fourth quarter worth $237,000. Zeke Capital Advisors LLC purchased a new position in Encompass Health in the fourth quarter worth $238,000. Finally, S. R. Schill & Associates purchased a new position in Encompass Health in the fourth quarter worth $401,000. 93.18% of the stock is currently owned by institutional investors and hedge funds.
About Encompass Health
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.